The current financial score of P3 Health Partners Inc is 7.18. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 386.38M, representing a year-over-year increase of 8.60%, while its net profit experienced a year-over-year increase of 89.56%.
The current valuation score of P3 Health Partners Inc is 9.80. Its current P/E ratio is 0.03, which is 95.53% below the recent high of 0.06 and 7472.52% above the recent low of -2.31.
The current earnings forecast score of P3 Health Partners Inc is 7.00. The average price target is 18.00, with a high of 23.00 and a low of 13.00.
The current price momentum score of P3 Health Partners Inc is 4.46. Currently, the stock price is trading between the resistance level at 10.27 and the support level at 7.42, making it suitable for range-bound swing trading.
The current institutional shareholding score of P3 Health Partners Inc is 3.00. The latest institutional shareholding proportion is 11.99%, representing a quarter-over-quarter increase of 9.17%.
The current risk assessment score of P3 Health Partners Inc is 3.63. The company's beta value is 1.79. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.